 |
 |

Prediction of Progression to Cirrhosis by a Glutathione S-Transferase P1 Polymorphism in Subjects With Hereditary Hemochromatosis
Felix Stickel, MD;
Christoph H. Österreicher, MD;
Christian Datz, MD;
Peter Ferenci, MD;
Marco Wölfel, BS;
Wolfgang Norgauer, MD;
Michael R. Kraus, MD, DSc;
Fritz Wrba, MD;
Claus Hellerbrand, MD;
Detlef Schuppan, MD, PhD
Arch Intern Med. 2005;165:1835-1840.
Background Oxidative stress plays an important pathogenic role in hereditary hemochromatosis (HHC) and chronic hepatitis C virus infection (CHC). Several enzymes involved in the degradation of reactive oxidants and xenobiotics, such as glutathione S-transferase P1 (GSTP1) and manganese superoxide dismutase (MnSOD), reveal polymorphisms that affect their antioxidant capacity and may therefore modulate the progression to cirrhosis. Our objective was to establish the role of the functional polymorphisms of GSTP1 (codon 105 Ile Val) and MnSOD (codon 16 of precursor protein Ala Val) on the evolution of cirrhosis in patients with HHC and CHC.
Methods One hundred seventy-two patients with HHC who were homozygous for the C282Y mutation and 285 patients with CHC underwent liver biopsy and genotyping for the GSTP1 and MnSOD polymorphisms.
Results In HHC, the GSTP1 Val/Val genotype was more common in patients with than in those without cirrhosis (14.8% vs 2.1%, P = .009), whereas the distribution of MnSOD variants was not different. Logistic regression analysis identified GSTP1 Val/Val genotype, serum ferritin level, male sex, and age as independent predictors for the presence of cirrhosis. The odds ratio for the GSTP1 Val/Val genotype for the development of cirrhosis was 3.85 (95% confidence interval, 1.18-12.62; P = .03). However, in patients with CHC, the GSTP1 and MnSOD genotypes were not associated with cirrhosis.
Conclusions Cirrhosis is more likely to develop in C282Y homozygotes with the GSTP1 Val/Val genotype than in those with non-Val/Val genotypes, which in part explains the variable phenotypic expression of HHC and highlights the central role of oxidative stress in its pathogenesis.
Author Affiliations: Department of Medicine I, University of Erlangen-Nürnberg, Erlangen, Germany (Drs Stickel and Schuppan and Mr Wölfel); Departments of Medicine IV (Drs Österreicher and Ferenci) and Clinical Pathology (Dr Wrba), University of Vienna, Vienna, Austria; Department of Medicine, Oberndorf Hospital, Salzburg, Austria (Dr Datz); Department of Medicine, Theresien Medical Center, Nürnberg, Germany (Dr Norgauer); Department of Medicine, University of Würzburg, Würzburg, Germany (Dr Kraus); and Department of Medicine I, University of Regensburg, Regensburg, Germany (Dr Hellerbrand).
RELATED ARTICLES
Practicing Medicine at the Front Lines of the Genomic Revolution
Wendy S. Rubinstein and Hemant K. Roy
Arch Intern Med. 2005;165(16):1815-1817.
EXTRACT
| FULL TEXT
Genetic Liability to Fractures in the Elderly
Karl Michaëlsson, Håkan Melhus, Helene Ferm, Anders Ahlbom, and Nancy L. Pedersen
Arch Intern Med. 2005;165(16):1825-1830.
ABSTRACT
| FULL TEXT
Ready for Genomic Medicine? Perspectives of Health Care Decision Makers
Paul R. Billings, Rick J. Carlson, Josh Carlson, Mary Cain, Charles Wilson, Peter Shorett, and Wendy Everett
Arch Intern Med. 2005;165(16):1917-1919.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis
Wood et al.
Blood 2008;111:4456-4462.
ABSTRACT
| FULL TEXT
Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis
Osterreicher et al.
Mutagenesis 2007;22:305-310.
ABSTRACT
| FULL TEXT
THE ROLE OF GENETIC POLYMORPHISMS IN ALCOHOLIC LIVER DISEASE
STICKEL and OSTERREICHER
Alcohol Alcohol 2006;41:209-224.
ABSTRACT
| FULL TEXT
Practicing Medicine at the Front Lines of the Genomic Revolution
Rubinstein and Roy
Arch Intern Med 2005;165:1815-1817.
FULL TEXT
|